MellingMedical Secures Federal Supply Schedule Contract to Aid Veterans' Healthcare
In a significant development for veterans' healthcare, MellingMedical has officially announced its recent achievement of a Federal Supply Schedule (FSS) contract focused on Drugs, Pharmaceuticals, and Hematology Products. The contract, designated as FSS 65IB (Contract 36F79725D0092), is set to be effective from March 15, 2025, to March 30, 2030. This strategic contract enables Department of Veterans Affairs (VA), the Department of Defense (DoD), and other federal medical facilities to easily procure essential pharmaceutical products.
Founded and led by veterans, MellingMedical expresses its commitment to enhancing the healthcare opportunities available to America's active-duty military and veteran service members. Chris Melling, the founder and CEO of MellingMedical, stated, "As a veteran-founded and veteran-led company, we are dedicated to creating pathways for the resources necessary for optimizing the care given to our service members. This new contract presents an efficient method for our partners to supply essential pharmaceutical products to U.S. federal healthcare customers."
The scope of the FSS contract includes a variety of essential products, which comprise over-the-counter drugs, antiseptics, eyelid cleansers, and nutritional supplements. Through this contract, MellingMedical aims to ensure that the procurement process for these pharmaceutical items is seamless and effective, contributing to improved healthcare outcomes for veterans.
The United States Government Services Administration (GSA) entrusts the VA to manage multiple award contracts related to medical equipment, supplies, and services. The VA’s FSS program is pivotal in servicing the healthcare needs of VA and federal government entities, with over $21 billion in sales and access to more than a million advanced commercial products and services.
MellingMedical, designated as a Service-Disabled Veteran-Owned Small Business (SDVOSB), is on a mission to offer innovative, cost-effective healthcare solutions across a wide array of federal institutions. These include 172 VA Medical Centers, 1,138 VA Outpatient Clinics, the seven VA Consolidated Mail Outpatient Pharmacies (CMOPs), 95 DoD Medical Facilities, and various Health and Human Services (HHS) branches, including the Indian Health Services (IHS) and the Centers for Disease Control (CDC).
For more insight into how to collaborate with MellingMedical or to delve deeper into their offerings, potential partners are encouraged to contact David Melling directly at [email protected] By winning this FSS contract, MellingMedical strengthens its capacity to serve U.S. veterans and their healthcare needs, highlighting its role as a key player in the federal healthcare market.
In conclusion, the awarding of this contract not only reflects MellingMedical's dedication to enhancing veterans' access to vital pharmaceuticals but also underscores its status as a trusted partner in the healthcare supply chain. As they move forward, the company is poised to make a meaningful impact in the lives of service members and veterans, ensuring they receive the healthcare support they rightfully deserve.
Founded and led by veterans, MellingMedical expresses its commitment to enhancing the healthcare opportunities available to America's active-duty military and veteran service members. Chris Melling, the founder and CEO of MellingMedical, stated, "As a veteran-founded and veteran-led company, we are dedicated to creating pathways for the resources necessary for optimizing the care given to our service members. This new contract presents an efficient method for our partners to supply essential pharmaceutical products to U.S. federal healthcare customers."
The scope of the FSS contract includes a variety of essential products, which comprise over-the-counter drugs, antiseptics, eyelid cleansers, and nutritional supplements. Through this contract, MellingMedical aims to ensure that the procurement process for these pharmaceutical items is seamless and effective, contributing to improved healthcare outcomes for veterans.
The United States Government Services Administration (GSA) entrusts the VA to manage multiple award contracts related to medical equipment, supplies, and services. The VA’s FSS program is pivotal in servicing the healthcare needs of VA and federal government entities, with over $21 billion in sales and access to more than a million advanced commercial products and services.
MellingMedical, designated as a Service-Disabled Veteran-Owned Small Business (SDVOSB), is on a mission to offer innovative, cost-effective healthcare solutions across a wide array of federal institutions. These include 172 VA Medical Centers, 1,138 VA Outpatient Clinics, the seven VA Consolidated Mail Outpatient Pharmacies (CMOPs), 95 DoD Medical Facilities, and various Health and Human Services (HHS) branches, including the Indian Health Services (IHS) and the Centers for Disease Control (CDC).
For more insight into how to collaborate with MellingMedical or to delve deeper into their offerings, potential partners are encouraged to contact David Melling directly at [email protected] By winning this FSS contract, MellingMedical strengthens its capacity to serve U.S. veterans and their healthcare needs, highlighting its role as a key player in the federal healthcare market.
In conclusion, the awarding of this contract not only reflects MellingMedical's dedication to enhancing veterans' access to vital pharmaceuticals but also underscores its status as a trusted partner in the healthcare supply chain. As they move forward, the company is poised to make a meaningful impact in the lives of service members and veterans, ensuring they receive the healthcare support they rightfully deserve.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.